CGGBP1 Activators
CGGBP1 activators encompass a diverse array of chemical compounds that enhance the functional activity of CGGBP1 through various cellular pathways. Forskolin, by increasing intracellular cAMP, indirectly promotes CGGBP1 activity through PKA-dependent phosphorylation processes, potentially affecting its DNA binding dynamics. On the other hand, EGF acts through the MAPK/ERK pathway to modulate transcription factors that could upregulate CGGBP1's functional capacity. Similarly, PMA's role in activating PKC could lead to enhanced CGGBP1 activity by influencing its regulatory protein interactions. Ionomycin, by raising intracellular calcium levels, may affect CGGBP1 through calcium-mediated signaling cascades, while insulin's impact on PI3K/Akt signaling has the potential to phosphorylate substrates that regulate CGGBP1, thereby enhancing its action.
In the realm of epigenetic modulation, sodium butyrate, as a histone deacetylase inhibitor, has the capability to remodel chromatin architecture, which can increase the accessibility of CGGBP1 to its target DNA sequences, thus boosting its gene regulatory functions. A-769662's activation of AMPK may indirectlyenhance CGGBP1 by modulating cellular energy balance and consequent downstream effects on DNA-binding proteins. Retinoic acid, through its activation of nuclear receptors, can influence the gene expression landscape in a manner that potentially supports CGGBP1's enhanced activity. Curcumin, with its wide-ranging effects on cellular signaling including the NF-kB pathway, could create a cellular milieu that augments CGGBP1's role in gene regulation. Lithium chloride's inhibition of GSK-3 and subsequent upregulation of beta-catenin could also enhance the transcriptional activity of genes under the control of CGGBP1. Lastly, resveratrol's activation of SIRT1 might modulate CGGBP1 activity by influencing deacetylation patterns on histones or other proteins associated with CGGBP1, impacting its interaction with chromatin and ability to regulate gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing cAMP levels. Elevated cAMP enhances protein kinase A (PKA) activity, which can lead to phosphorylation events that may increase CGGBP1 activity by altering its binding affinity or localization within the cell. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA functions as a diacylglycerol (DAG) analog, activating protein kinase C (PKC). PKC activation influences various transcription factors and signaling proteins that could enhance the DNA-binding activity of CGGBP1 through post-translational modifications. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-sensitive signaling pathways. This can indirectly enhance CGGBP1 activity by affecting the phosphorylation status of proteins that interact with or regulate CGGBP1. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin engages the insulin receptor, initiating a cascade that activates PI3K/Akt signaling. Akt can phosphorylate numerous substrates that may include regulatory proteins associated with CGGBP1, thus enhancing its functional activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that alters chromatin structure, potentially increasing accessibility to DNA for proteins like CGGBP1, thereby enhancing its ability to bind to its specific DNA sequences. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662 activates AMP-activated protein kinase (AMPK). Once activated, AMPK can initiate a variety of cellular responses that may include modifications to CGGBP1 activity through changes in cellular energy states. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences gene expression by activating retinoic acid receptors, which may alter the expression levels of proteins that regulate CGGBP1 function, thereby potentially enhancing its activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can affect multiple signaling pathways, including NF-kB, which may influence the expression or activity of CGGBP1 by modulating the cellular environment and the proteins that interact with CGGBP1. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, which may lead to the stabilization and increased activity of beta-catenin, a transcription co-activator that could enhance the expression of genes regulated by CGGBP1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuins, particularly SIRT1, which can deacetylate proteins and influence gene expression. This activation may impact the function of CGGBP1 by modulating its interaction with chromatin. | ||||||